v3.26.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-Based Compensation Cost and Associated Income Tax Benefits
Total stock-based compensation cost and the associated income tax benefits recognized in the Consolidated Statements of Operations, on a continuing operations basis, were as follows:
Year Ended March
(In thousands)202620252024
Stock-based compensation cost$76,954 $73,247 $57,829 
Income tax benefits17,729 16,299 12,849 
Schedule of Assumption Used and Resulting Weighted Average Fair Value of Stock Option Granted
The grant date fair value of each option award was calculated using a lattice option-pricing valuation model, which incorporated a range of assumptions for inputs as follows:
Year Ended March
2026 (a)
20252024
Expected volatility
N/A
37% to 53%
33% to 54%
Weighted average expected volatilityN/A47%42%
Expected term (in years)
N/A
5.5 to 7.3
5.9 to 7.8
Weighted average dividend yieldN/A2.2%3.7%
Risk-free interest rate
N/A
3.80% to 5.43%
3.80% to 5.50%
Weighted average fair value at date of grantN/A$5.31$5.74
(a)     Not applicable, as no options were granted during the year ended March 2026.
Schedule of Stock Option Activity
Stock option activity for the year ended March 2026 is summarized as follows:
Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value
(In thousands)
Outstanding, March 202517,080,438 $32.80 
Granted— — 
Exercised(536,970)15.60 
Forfeited/cancelled(3,616,393)54.38 
Outstanding, March 202612,927,075 $27.48 6.8$18,772 
Exercisable, March 20268,288,760 $34.63 6.2$7,619 
Schedule of RSU Activity
RSU and stock unit activity for the year ended March 2026 is summarized as follows:
 
Performance-based (a)
Nonperformance-based (b)
 
Number Outstanding (c)
Weighted Average
Grant Date
Fair Value		Number OutstandingWeighted Average
Grant Date
Fair Value
Outstanding, March 20252,401,772 $19.60 6,011,850 $18.70 
Granted885,143 6.76 5,967,873 12.74 
Issued as Common Stock— — (1,763,562)20.91 
Forfeited/cancelled(213,153)45.15 (862,869)15.56 
Outstanding, March 20263,073,762 $14.13 9,353,292 $14.77 
Vested, March 20261,079,163 $17.50 483,422 $16.49 
(a)Includes the portion of RSUs granted to executives in Fiscal 2026 that are subject to TSR targets, described in more detail above.
(b)Includes the portion of RSUs granted to executives in Fiscal 2026 that are not subject to TSR targets, described in more detail above.
(c)Reflects activity at target level of awards and has not been adjusted for performance and market conditions, except for awards issued during the period.
Schedule of Restricted Stock Activity
Restricted stock activity for the year ended March 2026 is summarized below:
Nonvested Shares OutstandingWeighted Average Grant Date Fair Value
Nonvested shares, March 202511,613 $71.43 
Granted— — 
Dividend equivalents— — 
Vested(11,613)71.43 
Forfeited— — 
Nonvested shares, March 2026— $—